SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-24-010041
Filing Date
2024-02-02
Accepted
2024-02-02 16:15:43
Documents
15
Period of Report
2024-02-01
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm245037d1_8k.htm   iXBRL 8-K 29041
2 EXHIBIT 3.1 tm245037d1_ex3-1.htm EX-3.1 222201
  Complete submission text file 0001104659-24-010041.txt   470877

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA imrx-20240201.xsd EX-101.SCH 3024
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE imrx-20240201_lab.xml EX-101.LAB 34240
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE imrx-20240201_pre.xml EX-101.PRE 22365
16 EXTRACTED XBRL INSTANCE DOCUMENT tm245037d1_8k_htm.xml XML 3889
Mailing Address 245 MAIN STREET, SECOND FLOOR CAMBRIDGE MA 02142
Business Address 245 MAIN STREET, SECOND FLOOR CAMBRIDGE MA 02142 617-500-8080
Immuneering Corp (Filer) CIK: 0001790340 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40675 | Film No.: 24591614
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)